There is lack of consensus in the literature regarding the comparative efficacy of in situ aortic-only compared with dual (aortic and portal venous) perfusion for retrieval and transplantation of the liver. Recipient outcomes from the Australia/New Zealand Liver Transplant Registry (2007-2016), including patient and graft survival and causes of graft loss, were stratified by perfusion route. Subgroup analyses were conducted for higher-risk donors. A total of 1382 liver transplantation recipients were analyzed (957 aortic-only; 425 dual perfusion). There were no significant differences in 5-year graft and patient survivals between the aortic-only and dual cohorts (80.1% versus 84.6% and 82.6% versus 87.8%, respectively) or in the odds ratios of primary nonfunction, thrombotic graft loss, or graft loss secondary to biliary complications or acute rejection. When analyzing only higher-risk donors (n = 369), multivariate graft survival was significantly less in the aortic-only cohort (hazard ratio, 0.49; 95% confidence interval, 0.26-0.92). Overall, there was a trend toward improved outcomes when dual perfusion was used, which became significant when considering higher-risk donors alone. Inferences into the ideal perfusion technique in multiorgan procurement will require further investigation by way of a randomized controlled trial, and outcomes after the transplantation of other organs will also need to be considered. Liver perfusion during deceased donor organ retrieval can be conducted by cannulation of the aorta and portal vein (dual perfusion) or via the abdominal aorta alone. Intuitively, aortic perfusion alone is simpler and faster to achieve compared to dual perfusion because it involves one less step during retrieval. Furthermore, aortic-only perfusion does not obstruct pancreatic venous outflow, unlike the dual perfusion cannula inserted via the inferior or superior mesenteric veins. (1, 2) There is controversy in the literature regarding the utility of each approach in comparison to the other. In a recent systematic review and meta-analysis, we showed that aortic and dual perfusion likely achieve equivalent outcomes for donation after brain death (DBD) standard criteria liver recipients. However, studies included in this comparison all had small sample sizes, and maximum recipient follow-up was 20 months. (3) (4) (5) (6) (7) (8) In contrast, D'Amico et al. compared the 2 techniques in 35 "suboptimal" grafts and showed significantly poorer outcomes in aortic-only perfused livers. (9) Overall, because of disparate results from existing studies, small patient numbers, and relatively short patient follow-up, retrieval guidelines with respect to the use of aortic-only or dual perfusion significantly vary between and within different jurisdictions. (8, (10) (11) (12) We therefore aimed to analyze the efficacy of aortic and dual perfusion using a larger national cohort Hameed et al.
Liver perfusion during deceased donor organ retrieval can be conducted by cannulation of the aorta and portal vein (dual perfusion) or via the abdominal aorta alone. Intuitively, aortic perfusion alone is simpler and faster to achieve compared to dual perfusion because it involves one less step during retrieval. Furthermore, aortic-only perfusion does not obstruct pancreatic venous outflow, unlike the dual perfusion cannula inserted via the inferior or superior mesenteric veins. (1, 2) There is controversy in the literature regarding the utility of each approach in comparison to the other. In a recent systematic review and meta-analysis, we showed that aortic and dual perfusion likely achieve equivalent outcomes for donation after brain death (DBD) standard criteria liver recipients. However, studies included in this comparison all had small sample sizes, and maximum recipient follow-up was 20 months. (3) (4) (5) (6) (7) (8) In contrast, D'Amico et al. compared the 2 techniques in 35 "suboptimal" grafts and showed significantly poorer outcomes in aortic-only perfused livers. (9) Overall, because of disparate results from existing studies, small patient numbers, and relatively short patient follow-up, retrieval guidelines with respect to the use of aortic-only or dual perfusion significantly vary between and within different jurisdictions. (8, (10) (11) (12) We therefore aimed to analyze the efficacy of aortic and dual perfusion using a larger national cohort Original article | 1537 with a prolonged period of follow-up. This cohort was analyzed as a whole, with further subgroup analyses conducted for higher-risk donor grafts. Recipient outcomes, including graft and patient survival and causes of graft loss, were stratified by perfusion route.
Patients and Methods

data cOllectiOn
The Australia and New Zealand Liver Transplant Registry and the Australia and New Zealand Organ Donation Registry were used for the collection of relevant study data collections. Both donor and recipient parameters were obtained. Donor characteristics were as follows: preservation fluid type(s), donor age, sex, cause of death (COD), liver enzymes, pressor requirements, state (region) of retrieval, and body mass index (BMI). Recipient characteristics obtained included the following: recipient age, sex, primary liver diagnosis, Model for End-Stage Liver Disease (MELD) score, graft number for the recipient, and recipient transplant center. Transplantation parameters recorded were cold ischemia time (CIT), secondary warm ischemia time (SWIT), graft utilization locally or interstate ("shipped"), graft and patient survival, reason for graft loss (primary nonfunction [PNF] , hepatic artery thrombosis [HAT] , portal vein thrombosis [PVT], biliary complications, and acute rejection), and the need for retransplantation. PNF was defined as the need for retransplantation and/or patient death within 7 days due to graft nonfunction. Each Australian state has a dedicated liver transplantation (LT) unit and distinct liver retrieval team(s). Graft retrieval technique (ie, aortic or dual perfusion) and back-table retrieval practices are not recorded in either database and were therefore obtained by surveying senior surgeons from each unit who performed the retrieval; the organ retrieval service in Australia is consultant-led. Retrieval team practices with regard to aortic or dual perfusion have remained consistent over the study period. Ethics approval for this project was obtained from the local institutional review board. No organs from executed prisoners were used.
stUdY inclUsiOn and eXclUsiOn criteria
Adult (≥16 years) Australian liver DBD donor and corresponding recipient data were analyzed for the period from January 2007 to December 2016. Partial liver donors (split or reduced-size grafts) were excluded from analyses, as were donors in whom University of Wisconsin (UW) solution was not used as the final perfusion and preservation fluid and patients who had a previous LT. Donation after circulatory death (DCD) donors could not be included because dual perfusion was not commonly employed in this donor subset.
retrieval tecHniQUe
All units employed a preflush, consisting of 2-4 L of either Hartmann's solution, 0.9% NaCl, or Ross/ Marshall's Hyperosmolar Citrate Solution (Soltran, Baxter Healthcare, Newbury, United Kingdom) given via the aorta, and in the cases of dual perfusion, also via the portal vein. This was followed by a formal UW flush of 4-8 L, again via the aorta, and in the cases of dual perfusion, also via the portal vein. Retrieval teams undertaking dual perfusion accessed the portal vein via a cannula inserted into the inferior mesenteric vein and unless the pancreas was also retrieved, in which case the portal vein was usually transected just proximal to the pancreas and accessed directly. The decision to undertake aortic or dual perfusion was specific to each retrieval unit and was not impacted by consideration of donor or recipient factors. All retrieval teams gave an additional back-table portal venous flush.
patient OUtcOmes and statistical analYses
Recipient data were stratified by the in situ perfusion route used: aortic or dual perfusion. Final outcomes of interest were graft survival (all cause), patient survival, and cause of graft loss (PNF, HAT, PVT, acute rejection, or biliary complications). All statistical analyses were undertaken using SPSS Statistics for Windows, version 24.0 (IBM, Armonk, NY) and Stata, version 14.0 (Stata Corp., College Station, TX).
Baseline patient data were compared using the Student t test or Mann-Whitney U test and the chisquare test or Fisher's exact test when appropriate. Survival data between study groups were compared using Kaplan-Meier curves with statistical significance obtained using the log-rank test. Cox regression models were constructed for graft and patient survival data, stratifying for aortic and dual perfusion and other relevant donor or recipient factors (donor/recipient sex, donor/recipient age, donor COD or recipient cause of liver failure, donor BMI, recipient MELD, CIT, SWIT, recipient transplant center, and graft shipping versus local use). Multivariate Cox regression models comparing aortic and dual perfusion survival outcomes were then constructed using a backward stepwise approach and included all univariate factors with a P value < 0.2 and/or baseline characteristics that were significantly different between both study cohorts. Model diagnostics were performed using the global proportional hazards test and Cox-Snell residuals. The level of data missingness was <5% for all variables used in Cox regression models with the exception of MELD, CIT, and SWIT, which were missing in 11.1%, 18.9%, and 20.4% of cases, respectively. The technique of multiple imputations was employed to account for any missing data using chained equations; 20 imputed data sets were created. Causes of graft loss were compared using Fisher's exact test and univariate and multivariate logistic regression.
sUBgrOUp analYsis
The donor risk index (DRI) (from the United States) characterizes the risk of liver graft failure based on the presence of donor age of >40 years and especially for donors who were >60 years, DCD donors, partial/split grafts, lower height, African American race, and cerebrovascular accident (CVA) or "other" COD for the donor. (13) Additional factors incorporated in the risk model are a CIT above 8 hours and regional or national shipping of organs. The Eurotransplant (ET) DRI uses the existing DRI score with the omission of donor race and height, and it further incorporates donor gamma-glutamyltransferase (GGT) above 50 and rescue liver offers as risk factors. (14) These indices
have not yet been validated in the Australian setting. We therefore only undertook subgroup graft survival and cause of graft loss analyses for the highest risk donors in our cohort, defined by age >60 years, COD "other" (ie, death unrelated to CVA, trauma, and/or anoxia), and/or with a CIT ≥ 12 hours. Graft shipping was not considered because it produced better outcomes than locally procured grafts (see Results), whereas donor height had no association with graft survival, donor race was not available, and donor GGT data were missing for a large proportion of patients.
Results
Baseline parameters
Over the study period, a total of 1382 LT recipients were included as they fulfilled the inclusion criteria. In total, 957 transplant livers were procured using aortic-only in situ perfusion in comparison to 425 livers in which dual perfusion was employed. Baseline study characteristics are summarized in Table 1 . There were no significant differences between aortic and dual groups with the exception of CIT, SWIT, and recipient MELD (7.0 versus 6.3 hours; 45.4 versus 37.8 minutes; and 18 versus 14, respectively; P < 0.001). Figure 1A shows the unadjusted Kaplan-Meier curve comparing aortic-only and dual perfusion. Actuarial 5-year graft survival rates were 80.1% for the aortic-only group compared with 84.6% for the dual group. Overall, there were no significant differences in graft survival (P = 0.07). Figure 1B shows the unadjusted Kaplan-Meier curve comparing aortic-only and dual perfusion with
all-caUse graFt lOss (WHOle cOHOrt)
Original article | 1539 respective actuarial 5-year patient survival rates of 82.6% and 87.8%. Overall patient survival was significantly lower in the aortic-only cohort ( Fig. 1B ; P = 0.03); after adjustment for confounders, there were no differences in patient survival between both perfusion groups (HR, 0.75; 95% CI, 0.53-1.06; P = 0.10 Table 2 ).
caUses OF graFt lOss (WHOle cOHOrt)
Different causes of graft loss were compared in LT recipients after aortic versus dual in situ perfusion, including PNF, HAT, PVT, biliary complications, and acute rejection (Table 3 ). There were no significant NOTE: Data are given as n (%), mean ± SD, or median (IQR). *"Unshipped" denotes graft used in the same state it was procured. For "Shipped," the numbers do not add up to 957 because shipping data are missing for 1 patient.
differences in unadjusted odds ratios (ORs) between recipients after aortic-only or dual perfusion in donors. Subsequent retransplantation rates among the 2 groups did not differ (OR, 1.05; 95% CI, 0.55-2.01; P = 0.88).
sUBgrOUp analYses OF HigHer risK dOnOrs
Baseline characteristics of the higher-risk donor subgroup are also shown in Table 1, while Tables 4 and  5 analyze graft/recipient survival and causes of graft loss, respectively. When analyzing only cases in which donors were >60 years, donor COD was "other," and/ or CIT was ≥12 hours, there were 278 recipients in the aortic-only cohort and 91 recipients in the dual perfusion cohort. Graft survival was significantly lower in the aortic-only cohort in comparison to dual perfusion using univariate Cox regression (HR, 0.52; 95% CI, 0.27-0.98; P = 0.04). This was also reflected in the unadjusted Kaplan-Meier curve (Fig. 1C) . After multivariate Cox regression, dual perfusion remained protective over aortic-only perfusion with respect to graft loss (HR, 0.49; 95% CI, 0.26-0.92; P = 0.03). Overall patient survival was not significantly different between either group upon univariate (Fig. 1D ) and multivariate analyses (HR, 0.58; 95% CI, 0.30-1.11; P = 0.10). There were no significant differences between groups with respect to causes of graft loss (Table 5) . 
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In this subset of patients, grafts that were transplanted within the same state did not have different outcomes when compared with shipped grafts (graft survival-HR, 1.00; 95% CI, 0.56-1.80; P = 0.99; patient survival-HR, 1.10; 95% CI, 0.60-2.02; P = 0.77. Furthermore, this parameter was not included in the final graft and patient survival models after multivariate analyses because it did not have a significant effect on the final model parameters (data not shown).
Discussion
This article has compared aortic-only in situ perfusion during DBD whole liver retrieval with dual aorto-portal perfusion with respect to recipient outcomes using a national registry over a 10-year period. When both standard and expanded-risk grafts are analyzed together, there are no significant differences in graft and patient survival or in causes of graft loss between either in situ perfusion technique. However, dual perfusion is superior when used in higher-risk donors, as defined by advanced age (>60 years), and/or COD "other," and/or with a prolonged CIT (≥12 hours).
The primary aim of in situ liver perfusion is to achieve rapid graft cooling and commence "preservation" by the expulsion of residual blood and exposing the graft parenchyma to cold preservation fluid. Despite the liver's dual circulation, aortic-only perfusion should theoretically be able to simultaneously achieve portal perfusion via the mesenteric venous drainage, albeit in a slightly delayed fashion. (6) Although appropriate liver perfusion takes longer when aortic-only perfusion is used, the final liver temperature achieved by either modality does not significantly differ (12.5°C ± 3.4°C versus 11°C ± 3°C for the aortic-only and dual-perfused livers, respectively; P > 0.05). (6) Accordingly, the short-term equivalence of both perfusion techniques with respect to graft outcomes (PNF and peak alanine aminotransferase) has been shown previously in our meta-analysis. (8) However, only standard criteria donor livers were considered, and there were insufficient data available for comparison of longer-term outcomes. (8) In concordance with these results from the meta-analysis, D'Amico et al. in their small cohort of patients showed 100% 6-month graft survival in optimal livers using either aortic or dual perfusion. However, there were significantly superior Original article | 1543 results in expanded criteria grafts after dual perfusion, and the trial was terminated early. (9) These authors conducted portal perfusion via a cannula inserted in the inferior mesenteric vein and additionally minimized/ reduced mesenteric venous return by tightening a tourniquet across the distal portal vein. (9, 15) Expanded criteria donors were defined by the presence of at least 1 feature of donor age >60 years, hepatic steatosis >20%, and/or total ischemia time >10 hours, or 2 out of other lesser arbitrary criteria. (9) Interestingly and perhaps surprisingly, when comparing the higher-risk donor subgroup within each perfusion cohort, we have also now shown superior graft survival outcomes in the higher-risk dual perfusion group, despite the use of a back-table portal venous flush in all patients. Our definition of higher-risk donors incorporated factors from the DRI/ ET-DRI, albeit without the inclusion of some factors such as graft shipping that did not fit the data set used. Recipient parameters were not considered in the subgroup analyses for the same reason that they are not included in risk scores such as the DRI because the idea is to facilitate an appropriate donor-recipient match based on the characteristics of the donor organ.
Unexpectedly, we also found that shipped grafts had better outcomes in comparison to unshipped grafts, even after accounting for multiple confounders. The only significant difference between both groups was mean donor age (40.2 and 43.1 years for shipped and unshipped grafts, respectively; P = 0.030), whereas CIT, SWIT, donor COD, perfusion route, and recipient characteristics did not significantly differ. Interestingly, shipping did not significantly impact outcomes in the higher-risk donor cohort. This finding is difficult to explain and warrants further investigation, although it may relate to center-level transplantation practices and patient selection, which could not be fully accounted for in our models, and altered retrieval-related practices in anticipation of shipping.
The influence of either perfusion method on pancreas transplantation outcomes in the context of multiorgan procurement is yet to be definitively ascertained. Dual perfusion adds theoretical risks when the pancreas is to be retrieved, due to pancreatic congestion from the potential blockage of pancreas perfusate outflow secondary to the portal venous catheter. (1, 2) This can be avoided by transecting the portal vein immediately proximal to the pancreas and inserting the cannula directly into the proximal portal vein. (16) The ideal perfusion approach during combined liver and pancreas retrieval must account for the impact on both organs, and the relative risks and benefits weighed especially against the lifesaving nature of LT.
Database analyses have inherent disadvantages that must be acknowledged. Missing data, inconsistent recording, and loss to follow-up patients are some clear limitations. Furthermore, each center had slightly different perfusion protocols within the aortic-only and dual perfusion groups, which may have made a small impact on results. Most importantly, each state in Australia has 1 LT unit that may vary with respect to donor and recipient selection. As aortic and dual perfusion practices tend to split by individual units, our results will at least somewhat reflect differing unit patient selection bias. However, because the majority of livers retrieved within a state are also transplanted in the same state, we incorporated the transplant center in multivariate analyses to help account for any confounding introduced by this factor. The perfusion/ preservation fluid used can impact graft outcomes, and as such, only grafts that were given a UW final flush and preservation were included. (17, 18) The exclusion of partial LTs and patients undergoing repeat transplantation slightly narrows the generalizability of this analysis. However, this was deemed necessary because of a likely significant confounding of results. (13, 19, 20) At the least, results from this review warrant further confirmation and investigation in the form of a multicenter trial with prolonged recipient follow-up.
Any such trial should also analyze pancreas transplantation outcomes in recipients from the same donor. Another future consideration is any potential impact of hypothermic and/or normothermic perfusion of the liver, which has not yet been clinically implemented in Australasia but is gaining significant prominence in the global setting. (21, 22) NOTE: Data are given as n (%).
The ultimate goal of organ retrieval in the age of multiorgan procurement should be a unified approach among all retrieval surgeons and units that maximizes organ yield and transplantation outcomes from the different organs retrieved. Transplant centers should endeavor to collaboratively investigate and discuss this issue, and they should organize further studies, such that uniform global guidelines can be developed.
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